Trial Profile
An Open-Label, Randomized, Multicenter, Two-Arms Efficacy and Safety Study of 14 Days Treatment With Finafloxacin 400 mg b.i.d. Plus Amoxicillin 1000 mg b.i.d.Versus Finafloxacin 400 mg b.i.d. Plus Esomeprazole 40 mg b.i.d. in Patients With Helicobacter Pylori Infection.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2012
Price :
$35
*
At a glance
- Drugs Finafloxacin (Primary) ; Amoxicillin; Esomeprazole
- Indications Dyspepsia; Helicobacter pylori infections
- Focus Therapeutic Use
- Acronyms FLASH
- Sponsors MerLion Pharmaceuticals
- 17 Jun 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 17 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Oct 2008 Planned end date changed from 1 Dec 2008 to 1 Nov 2008 as reported by ClinicalTrials.gov.